Journal of the International Society of Sports Nutrition

Table 3 Effects of DHA diet supplementation and exercise on PBMCs gene expression

From: Effects of dietary Docosahexaenoic, training and acute exercise on lipid mediators

		Basal	Post-exercise	ANOVA
		Basal	Post-exercise	S	E	SxE	Fd
NFκβ (AU)	Placebo	1.00 ± 0.22	1.21 ± 0.31	.576 (f = .373)	.369 (f = .142)	.906 (f = .006)	(3,42)
NFκβ (AU)	Experimental	1.33 ± 0.33	1.46 ± 0.33	.576 (f = .373)	.369 (f = .142)	.906 (f = .006)	(3,42)
COX-2 (AU)	Placebo	1.00 ± 0.28	1.99 ± 0.86	.355 (f = .026)	.726 (f = .592)	.513 (f = .142)	(3,42)
COX-2 (AU)	Experimental	1.46 ± 0.45	1.80 ± 0.51	.355 (f = .026)	.726 (f = .592)	.513 (f = .142)	(3,42)
15-LOX2 (AU)	Placebo	1.00 ± 0.37	1.43 ± 0.76	.402 (f = .717)	.973 (f = .001)	.983 (f = .000)	(3,45)
15-LOX2 (AU)	Experimental	1.03 ± 0.30	1.43 ± 0.43	.402 (f = .717)	.973 (f = .001)	.983 (f = .000)	(3,45)
5-LOX (AU)	Placebo	1.00 ± 0.28	1.10 ± 0.42	.694 (f = .109)	.742 (f = .157)	.956 (f = .003)	(3,52)
5-LOX (AU)	Experimental	0.89 ± 0.21	1.02 ± 0.18	.694 (f = .109)	.742 (f = .157)	.956 (f = .003)	(3,52)
IL1β (AU)	Placebo	1.00 ± 0.34	0.84 ± 0.17	.906 (f = .000)	.998 (f = .014)	.496 (f = .472)	(3,42)
IL1β (AU)	Experimental	0.80 ± 0.22	1.03 ± 0.29	.906 (f = .000)	.998 (f = .014)	.496 (f = .472)	(3,42)

Statistical analysis: Two-way ANOVA. (S) Significant effect of supplementation, (E) Significant effect of exercise, (SxE) Significant interaction between both factors. (#)Significant differences between Placebo and Experimental groups. (*)Significant differences between the Pre-exercise and Post-exercise. p < 0.05. When interaction exists between different groups, different letters reveal significant differences. Results are the mean ± SEM. Fd means Freedom degree. AU means arbitrary units referred to Pre-exercise Placebo values

Back to article page

ISSN: 1550-2783

Contact us

Submission enquiries: Access here and click Contact Us
General enquiries: info@biomedcentral.com